Bacterial proteinases as targets for the development of second-generation antibiotics.
The emergence of bacterial pathogen resistance to common antibiotics strongly supports the necessity to develop alternative mechanisms for combating drug-resistant forms of these infective organisms. Currently, few pharmaceutical companies have attempted to investigate the possibility of interrupting metabolic pathways other than those that are known to be involved in cell wall biosynthesis. In this review, we describe multiple, novel roles for bacterial proteinases during infection using, as a specific example, the enzymes from the organism Porphyromonas gingivalis, a periodontopathogen, which is known to be involved in the development and progression of periodontal disease. In this manner, we are able to justify the concept of developing synthetic inhibitors against members of this class of enzymes as potential second-generation antibiotics. Such compounds could not only prove valuable in retarding the growth and proliferation of bacterial pathogens but also lead to the use of this class of inhibitors against invasion by other infective organisms.
Travis
J
J
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA. jtravis@arches.uga.edu
Potempa
J
J
D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D001419:Bacteria / Q000201:enzymology* / Q000472:pathogenicity; D015195:Drug Design; D004352:Drug Resistance, Microbial; D010450:Endopeptidases / Q000378:metabolism*; D008969:Molecular Sequence Data; D010518:Periodontitis / Q000276:immunology / Q000382:microbiology; D016966:Porphyromonas gingivalis / Q000201:enzymology / Q000472:pathogenicity; D011480:Protease Inhibitors / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D011480:Protease Inhibitors; D010450:Endopeptidases